Resource id #3DrugId:1d00000108resource(4) of type (mysql result) Drug Search

Main    A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    Main   

Drug ID: 1d00000108

Drug Name: Antihemophiliac factor

Generic Names: Fanhdi | Haemoctin Sdh Factor Viii | Hemofil-M | Monoclate-P | Advate | Xyntha | Helixate NexGen | Helixate FS | Bioclate | Kogenate FS | Recombinate | ReFacto | Wilate | Alphanate | Hemofil M Method M Monoclonal Purified | Humate-P | Koate-DVI | Monarc-M Method M Monoclonal Purified | Monoclate-P

Category: Antihemophilics

Legal Status: Non Opioid Prescription only drug


Indication for Mother: Category C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Recommended Dose: The recommended dose is 5 10 U/kg, repeated 6 to 12 hourly.

Recommended In: This medication is an essential blood-clotting factor, prescribed for controlling and preventing bleeding episodes in people with low levels of factor VIII (hemophilia A) and AHG deficiency. This product contains a man-made form of factor VIII, also called antihemophilic factor. This temporarily replaces the missing factor VIII, a protein (clotting factor) that is normally in the blood, so that the blood can clot and the bleeding can stop.

Directions For Use: It comes as a solution for injection to be administered by a healthcare provider into the vein. Warm diluent (Sterile Water for Injection, USP) and concentrate (Alphanate (antihemophilic factor) ) to at least room temperature (but not above 37 C).

Storage: Store it in refrigerator (2 to 8C), do not freeze it. May be stored at room temperature not to exceed 30 C for up to 2 months.

Dosage Forms: Reconstituted powder for IV injection

Side Effects: Central Nervous System - Dizziness and headache.

Skin - Itching, flushing of face, hives, swelling of face, lips, tongue, or throat, burning/redness/irritation at the injection site and unusual bruising or bleeding.

Gastrointestinal - Stomach upset, stomach pain, loss of appetite, nausea, vomiting and sore throat.

Miscellaneous - Fever, chills, difficulty in breathing, fast heart beat and chest tightness.

In Case of Overdose: No symptoms of overdose with Antihemophiliac factor have been reported.

Avoid If: Caution needed in pregnant and breastfeeding women.

This medication should not be used to treat von Willebrand disease.

It may cause dizziness, do not drive a car or operate machinery while taking this medication.

Avoid excess dosage. Should not be administered at a rate exceeding 10 mL/minute. Rapid administration of a Factor VIII concentrate may result in vasomotor reactions.

Drug Interaction: There are no known drug interactions reported with Antihemophiliac factor. Drug interaction studies have not been performed.

Main    A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    Main